Identification of naturally processed CD4 T cell epitopes from the prostate-specific antigen kallikrein 4 using peptide-based in vitro stimulation

Journal of Immunology

Volumn 169, Issue 1, 2002, Pages 557-565

  Hural, John A ^a   Friedman, Rachel S ^a   McNabb, Andria ^a   Steen, Sean S ^a   Henderson, Robert A ^a   Kalos, Michael ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CD4 ANTIGEN; GAMMA INTERFERON; HLA DP ANTIGEN; HLA DR ANTIGEN; KALLIKREIN; PROSTATE SPECIFIC ANTIGEN; RECOMBINANT PROTEIN;

ARTICLE; CELL LYSATE; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HLA TYPING; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROSTATE CANCER; T LYMPHOCYTE; TISSUE SPECIFICITY; VACCINATION;

EID: 0036644723     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.1.557     Document Type: Article

References (29)

1. Cancer statistics, 2000
2. The course of metastatic disease originating from carcinoma of the prostate
3. Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells
4. Distinctly different gene structure of KLK4/KLK-L1/prostase/ARM1 compared with other members of the kallikrein family: Intracellular localization, alternative cDNA forms, and regulation by multiple hormones
5. Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression
6. Localization of a new prostate-specific antigen-related serine protease gene. KLK4, is evidence for an expanded human kallikrein gene family cluster on chromosome 19q13.3-13.4
7. Prostase/KLK-L1 is a new member of the human kallikrein gene family, is expressed in prostate and breast tissues, and is hormonally regulated
8. The expanded human kallikrein (KLK) gene family: Genomic organisation, tissue-specific expression and potential functions
9. The expanded human kallikrein gene family: Locus characterization and molecular cloning of a new member, KLK-L3 (KLK9)
10. Human kallikrein 4 (klk4) is highly expressed in serous ovarian carcinomas
11. Kallikrein 4 (KLK4), a new member of the human kallikrein gene family, is up-regulated by estrogen and progesterone in the human endometrial cancer cell line, KLE
12. Identification of exon I of prostase/KLK-L1 gene
13. + T cells requires tumor responsiveness to IFN-γ
14. + T cells in the antitumor immune response
15. + T cells have a major "post-licensing" role in CTL-mediated antitumor immunity
16. + T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN-γ receptor expression by nonhematopoietic cells
17. + T cells
18. + T cells
19. Naturally occurring prostate cancer antigen-specific T cell responses of a Th1 phenotype can be detected in patients with prostate cancer
20. + T lymphocytes
21. + T cells
22. + cytolytic T lymphocytes
23. A simplified system for generating recombinant adenoviruses
24. Generation of mature dendritic cells from human blood: An improved method with special regard to clinical applicability
25. Molecular cloning of the human kallikrein 15 gene (KLK15): Up-regulation in prostate cancer
26. Higher human kallikrein gene 4 (klk4) expression indicates poor prognosis of ovarian cancer patients
27. + T cells in antitumor immunity
28. + T cells: New strategies for cancer vaccine design
29. Expression of a tolerizing tumor antigen in peripheral tissue does not preclude recovery of high-affinity CD8+ T cells or CTL immunotherapy of tumors expressing the antigen